Literature DB >> 18265301

Overview of the vaccinia virus expression system.

Bernard Moss1, Patricia L Earl.   

Abstract

The vaccinia virus expression system differs from others in that transcription occurs in the cytoplasm of mammalian cells rather than in the nucleus. As a vector, vaccinia virus has a number of useful characteristics, including a capacity that permits cloning large fragments of foreign DNA (20+ kbp) with retention of infectivity, a wide host range, a relatively high level of protein synthesis, and "appropriate" transport, secretion, processing, and posttranslational modifications as dictated by the primary structure of the expressed protein and the cell type used. This overview discusses the life cycle of the vaccinia virus along with effects of vaccinia infection. The vaccinia vector expression system is described along with specific steps for expressing genes using these vectors. Important safety considerations are also presented.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 18265301     DOI: 10.1002/0471142727.mb1615s60

Source DB:  PubMed          Journal:  Curr Protoc Mol Biol        ISSN: 1934-3647


  3 in total

1.  First-in-man study of western reserve strain oncolytic vaccinia virus: safety, systemic spread, and antitumor activity.

Authors:  Herbert J Zeh; Stephanie Downs-Canner; J Andrea McCart; Zong Sheng Guo; Uma N M Rao; Lekshmi Ramalingam; Stephen H Thorne; Heather L Jones; Pawel Kalinski; Eva Wieckowski; Mark E O'Malley; Manijeh Daneshmand; Kang Hu; John C Bell; Tae-Ho Hwang; Anne Moon; Caroline J Breitbach; David H Kirn; David L Bartlett
Journal:  Mol Ther       Date:  2014-10-08       Impact factor: 11.454

2.  Structure-function analysis of vaccinia virus H7 protein reveals a novel phosphoinositide binding fold essential for poxvirus replication.

Authors:  Swapna Kolli; Xiangzhi Meng; Xiang Wu; Djoshkun Shengjuler; Craig E Cameron; Yan Xiang; Junpeng Deng
Journal:  J Virol       Date:  2014-12-03       Impact factor: 5.103

3.  A concept of eliminating nonhomologous recombination for scalable and safe AAV vector generation for human gene therapy.

Authors:  Biao Dong; Andrea R Moore; Jihong Dai; Sean Roberts; Kirk Chu; Philipp Kapranov; Bernard Moss; Weidong Xiao
Journal:  Nucleic Acids Res       Date:  2013-05-15       Impact factor: 16.971

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.